Details for New Drug Application (NDA): 083919
✉ Email this page to a colleague
NDA 083919 describes MILTOWN, which is a drug marketed by Medpointe Pharm Hlc and is included in two NDAs. Additional details are available on the MILTOWN profile page.
The generic ingredient in MILTOWN is meprobamate. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the meprobamate profile page.
The generic ingredient in MILTOWN is meprobamate. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the meprobamate profile page.
Summary for 083919
| Tradename: | MILTOWN |
| Applicant: | Medpointe Pharm Hlc |
| Ingredient: | meprobamate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 083919
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 600MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
